Library / regulatory-reference
Philippines: Food and Drug Administration (FDA Philippines)
Audience: administrators-policy, researchers-scientists ยท Review state: published
The national authority
The Food and Drug Administration of the Philippines is the country's national regulator for medicines, medical devices, vaccines, food, cosmetics and household hazardous substances, operating under the Department of Health.
The agency serves one of Southeast Asia's largest and most dispersed populations, and its remit covers both modern pharmaceuticals and the traditional and herbal products widely used in the country.
How products enter the market
Medicines require a certificate of product registration before marketing, following evaluation of quality, safety and efficacy, with electronic submission systems introduced to manage application volume. The agency also licenses drug manufacturers, importers, distributors and retail outlets.
Medical devices moved to a risk-based registration framework aligned with regional harmonization, and the agency issues public advisories and product recalls as part of its post-market surveillance.
Regional and international role
The Philippine FDA participates in Southeast Asian harmonization work and international regulatory cooperation, and its reliance-informed approach gives weight to assessments from established reference authorities for certain pathways.
The country's large overseas workforce and its role as a regional clinical-trials site keep the agency engaged with international standards and cross-border supply chains.
Using this profile
The agency publishes registers, advisories and guidance in English through its official portal, which is the primary source for current rules and listed in this profile's internal reference record.
For cross-country comparison: the Philippine FDA illustrates the archipelago regulator, managing a dispersed market with electronic registration systems and a public-advisory culture aimed at a widely distributed population.
Limitations
Educational profile of a national regulatory system, current as of drafting. It simplifies routes and classes and is not legal, regulatory, or clinical advice. Filing and compliance decisions must be confirmed against the authority's current published rules and, where needed, professional regulatory counsel.